vs

Side-by-side financial comparison of ESAB Corp (ESAB) and STEPAN CO (SCL). Click either name above to swap in a different company.

ESAB Corp is the larger business by last-quarter revenue ($727.8M vs $604.5M, roughly 1.2× STEPAN CO). ESAB Corp runs the higher net margin — 7.5% vs 3.3%, a 4.3% gap on every dollar of revenue. On growth, ESAB Corp posted the faster year-over-year revenue change (8.5% vs 1.9%). Over the past eight quarters, STEPAN CO's revenue compounded faster (4.2% CAGR vs 2.8%).

ESAB, Elektriska Svetsnings-Aktiebolaget, is an American-Swedish industrial company.

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

ESAB vs SCL — Head-to-Head

Bigger by revenue
ESAB
ESAB
1.2× larger
ESAB
$727.8M
$604.5M
SCL
Growing faster (revenue YoY)
ESAB
ESAB
+6.6% gap
ESAB
8.5%
1.9%
SCL
Higher net margin
ESAB
ESAB
4.3% more per $
ESAB
7.5%
3.3%
SCL
Faster 2-yr revenue CAGR
SCL
SCL
Annualised
SCL
4.2%
2.8%
ESAB

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
ESAB
ESAB
SCL
SCL
Revenue
$727.8M
$604.5M
Net Profit
$54.8M
$19.7M
Gross Margin
37.0%
10.7%
Operating Margin
14.6%
4.7%
Net Margin
7.5%
3.3%
Revenue YoY
8.5%
1.9%
Net Profit YoY
2.1%
EPS (diluted)
$0.90
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESAB
ESAB
SCL
SCL
Q1 26
$604.5M
Q4 25
$727.8M
$553.9M
Q3 25
$715.6M
$590.3M
Q2 25
$678.1M
$594.7M
Q1 25
$593.3M
Q4 24
$670.8M
$525.6M
Q3 24
$673.3M
$546.8M
Q2 24
$707.1M
$556.4M
Net Profit
ESAB
ESAB
SCL
SCL
Q1 26
$19.7M
Q4 25
$54.8M
$5.0M
Q3 25
$66.9M
$10.8M
Q2 25
$67.4M
$11.3M
Q1 25
$19.7M
Q4 24
$53.7M
$3.4M
Q3 24
$68.2M
$23.6M
Q2 24
$82.9M
$9.5M
Gross Margin
ESAB
ESAB
SCL
SCL
Q1 26
10.7%
Q4 25
37.0%
9.3%
Q3 25
37.2%
12.0%
Q2 25
37.6%
12.1%
Q1 25
12.7%
Q4 24
38.5%
10.8%
Q3 24
37.7%
13.8%
Q2 24
38.2%
12.5%
Operating Margin
ESAB
ESAB
SCL
SCL
Q1 26
4.7%
Q4 25
14.6%
1.9%
Q3 25
15.2%
3.7%
Q2 25
16.2%
3.0%
Q1 25
4.8%
Q4 24
16.6%
1.5%
Q3 24
15.7%
4.4%
Q2 24
16.9%
3.4%
Net Margin
ESAB
ESAB
SCL
SCL
Q1 26
3.3%
Q4 25
7.5%
0.9%
Q3 25
9.3%
1.8%
Q2 25
9.9%
1.9%
Q1 25
3.3%
Q4 24
8.0%
0.6%
Q3 24
10.1%
4.3%
Q2 24
11.7%
1.7%
EPS (diluted)
ESAB
ESAB
SCL
SCL
Q1 26
$0.86
Q4 25
$0.90
$0.22
Q3 25
$1.09
$0.47
Q2 25
$1.10
$0.50
Q1 25
$0.86
Q4 24
$0.87
$0.14
Q3 24
$1.11
$1.03
Q2 24
$1.35
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESAB
ESAB
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$218.2M
Total DebtLower is stronger
$1.3B
$328.4M
Stockholders' EquityBook value
$2.1B
$1.2B
Total Assets
$4.9B
$2.3B
Debt / EquityLower = less leverage
0.63×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESAB
ESAB
SCL
SCL
Q1 26
Q4 25
$218.2M
$132.7M
Q3 25
$258.2M
$118.5M
Q2 25
$291.3M
$88.9M
Q1 25
$107.5M
Q4 24
$249.4M
$99.7M
Q3 24
$253.7M
$147.3M
Q2 24
$228.5M
$124.7M
Total Debt
ESAB
ESAB
SCL
SCL
Q1 26
$328.4M
Q4 25
$1.3B
$626.7M
Q3 25
$1.1B
$655.5M
Q2 25
$1.1B
$658.0M
Q1 25
$659.3M
Q4 24
$1.1B
$625.4M
Q3 24
$1.1B
$688.5M
Q2 24
$1.1B
$657.1M
Stockholders' Equity
ESAB
ESAB
SCL
SCL
Q1 26
$1.2B
Q4 25
$2.1B
$1.2B
Q3 25
$2.1B
$1.2B
Q2 25
$1.9B
$1.2B
Q1 25
$1.2B
Q4 24
$1.8B
$1.2B
Q3 24
$1.8B
$1.2B
Q2 24
$1.7B
$1.2B
Total Assets
ESAB
ESAB
SCL
SCL
Q1 26
$2.3B
Q4 25
$4.9B
$2.4B
Q3 25
$4.4B
$2.4B
Q2 25
$4.2B
$2.4B
Q1 25
$2.4B
Q4 24
$4.0B
$2.3B
Q3 24
$4.1B
$2.4B
Q2 24
$4.0B
$2.3B
Debt / Equity
ESAB
ESAB
SCL
SCL
Q1 26
0.28×
Q4 25
0.63×
0.50×
Q3 25
0.51×
0.53×
Q2 25
0.55×
0.53×
Q1 25
0.55×
Q4 24
0.60×
0.53×
Q3 24
0.59×
0.56×
Q2 24
0.63×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESAB
ESAB
SCL
SCL
Operating Cash FlowLast quarter
$81.5M
Free Cash FlowOCF − Capex
$70.3M
FCF MarginFCF / Revenue
9.7%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
1.49×
TTM Free Cash FlowTrailing 4 quarters
$238.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESAB
ESAB
SCL
SCL
Q1 26
Q4 25
$81.5M
$60.0M
Q3 25
$46.6M
$69.8M
Q2 25
$35.4M
$11.2M
Q1 25
$6.9M
Q4 24
$126.9M
$68.3M
Q3 24
$101.0M
$22.7M
Q2 24
$83.0M
$29.5M
Free Cash Flow
ESAB
ESAB
SCL
SCL
Q1 26
Q4 25
$70.3M
$25.4M
Q3 25
$37.4M
$40.2M
Q2 25
$28.1M
$-14.4M
Q1 25
$-25.8M
Q4 24
$102.2M
$32.1M
Q3 24
$90.4M
$-4.0M
Q2 24
$74.0M
$-208.0K
FCF Margin
ESAB
ESAB
SCL
SCL
Q1 26
Q4 25
9.7%
4.6%
Q3 25
5.2%
6.8%
Q2 25
4.1%
-2.4%
Q1 25
-4.3%
Q4 24
15.2%
6.1%
Q3 24
13.4%
-0.7%
Q2 24
10.5%
-0.0%
Capex Intensity
ESAB
ESAB
SCL
SCL
Q1 26
Q4 25
1.5%
6.3%
Q3 25
1.3%
5.0%
Q2 25
1.1%
4.3%
Q1 25
5.5%
Q4 24
3.7%
6.9%
Q3 24
1.6%
4.9%
Q2 24
1.3%
5.3%
Cash Conversion
ESAB
ESAB
SCL
SCL
Q1 26
Q4 25
1.49×
11.99×
Q3 25
0.70×
6.44×
Q2 25
0.53×
0.99×
Q1 25
0.35×
Q4 24
2.36×
20.38×
Q3 24
1.48×
0.96×
Q2 24
1.00×
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESAB
ESAB

Consumable Products$477.9M66%
Equipment Products$249.9M34%

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

Related Comparisons